Fluoroclebopride is primarily utilized in the field of medical research and pharmacology due to its properties as a dopamine D2 receptor antagonist. It is often employed in studies focused on understanding the mechanisms of dopamine receptors and their role in neurological and psychiatric disorders. Researchers use it to investigate conditions such as schizophrenia, Parkinson's disease, and other dopamine-related dysfunctions. Additionally, it serves as a tool in the development and testing of new therapeutic agents targeting dopamine pathways. Its application extends to preclinical studies where it helps in evaluating the efficacy and safety of potential drugs aimed at modulating dopamine receptor activity.